Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria-Luisa del Rio

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Immunobiology|October 20, 2009
Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variantsMaria-Luisa del Rio, Jonathan Kaye, Jose-Ignacio Rodriguez-Barbosa
Transplant International : Official Journal of the European Society for Organ Transplantation|February 1, 2011
Flt3L-mobilized dendritic cells bearing H2-Kbm1 apoptotic cells do not induce cross-tolerance to CD8+ T cells across a class I MHC mismatched barrierMaria-Luisa del Rio, Javier Cote-Sierra, Jose-Ignacio Rodriguez-Barbosa
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cellsMaria-Luisa del Rio, Jose-Ignacio Rodriguez-Barbosa, Elisabeth Kremmer, et al.
Immunological Reviews|March 3, 2010
Development and functional specialization of CD103+ dendritic cellsMaria-Luisa del Rio, Günter Bernhardt, Jose-Ignacio Rodriguez-Barbosa, et al.
Frontiers in Immunology|July 7, 2022
Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid ResistanceMaria-Luisa Del Rio, Jose-Antonio Perez-Simon, Jose-Ignacio Rodriguez-Barbosa
Xenotransplantation|August 24, 2013
ITIM-dependent negative signaling pathways for the control of cell-mediated xenogeneic immune responsesMaria-Luisa del Rio, Jörg D Seebach, Carlos Fernández-Renedo, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 30, 2008
PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantationMaria-Luisa del Rio, Leo Buhler, Carrie Gibbons, et al.
Microscopy Research and Technique|October 21, 2022
Identification of Hypoderma actaeon (Diptera: Oestridae) in red deer (Cervus elaphus) from northern Spain: Microscopy study and molecular analysisSara González, Maria Luisa Del Rio, Maria Natividad Diez, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2020
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor modelJose-Ignacio Rodriguez-Barbosa, Miyuki Azuma, Gennadiy Zelinskyy, et al.
Xenotransplantation|May 11, 2007
Blockade of the PD-1/PD-1L pathway reverses the protective effect of anti-CD40L therapy in a rat to mouse concordant islet xenotransplantation modelGang Mai, Maria-Luisa del Rio, Jiong Tian, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Immunobiology|October 20, 2009
Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variantsMaria-Luisa del Rio, Jonathan Kaye, Jose-Ignacio Rodriguez-Barbosa
Transplant International : Official Journal of the European Society for Organ Transplantation|February 1, 2011
Flt3L-mobilized dendritic cells bearing H2-Kbm1 apoptotic cells do not induce cross-tolerance to CD8+ T cells across a class I MHC mismatched barrierMaria-Luisa del Rio, Javier Cote-Sierra, Jose-Ignacio Rodriguez-Barbosa
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cellsMaria-Luisa del Rio, Jose-Ignacio Rodriguez-Barbosa, Elisabeth Kremmer, et al.
Immunological Reviews|March 3, 2010
Development and functional specialization of CD103+ dendritic cellsMaria-Luisa del Rio, Günter Bernhardt, Jose-Ignacio Rodriguez-Barbosa, et al.
Frontiers in Immunology|July 7, 2022
Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid ResistanceMaria-Luisa Del Rio, Jose-Antonio Perez-Simon, Jose-Ignacio Rodriguez-Barbosa
Xenotransplantation|August 24, 2013
ITIM-dependent negative signaling pathways for the control of cell-mediated xenogeneic immune responsesMaria-Luisa del Rio, Jörg D Seebach, Carlos Fernández-Renedo, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 30, 2008
PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantationMaria-Luisa del Rio, Leo Buhler, Carrie Gibbons, et al.
Microscopy Research and Technique|October 21, 2022
Identification of Hypoderma actaeon (Diptera: Oestridae) in red deer (Cervus elaphus) from northern Spain: Microscopy study and molecular analysisSara González, Maria Luisa Del Rio, Maria Natividad Diez, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2020
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor modelJose-Ignacio Rodriguez-Barbosa, Miyuki Azuma, Gennadiy Zelinskyy, et al.
Xenotransplantation|May 11, 2007
Blockade of the PD-1/PD-1L pathway reverses the protective effect of anti-CD40L therapy in a rat to mouse concordant islet xenotransplantation modelGang Mai, Maria-Luisa del Rio, Jiong Tian, et al.
Pageof 3